Education
About Us
Working with TipRanks
Follow Us
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
Total Valuation
Belite Bio, Inc. ADR has a market cap or net worth of $1.86B. The enterprise value is $1.33B.
Market Cap$1.86B
Enterprise Value$1.33B
Share Statistics
Belite Bio, Inc. ADR has 32,281,760 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,281,760
Owned by Insiders7.30%
Owned by Institutions0.53%
Financial Efficiency
Belite Bio, Inc. ADR’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee0.00
Profits Per Employee-1.27M
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Belite Bio, Inc. ADR is -38.46. Belite Bio, Inc. ADR’s PEG ratio is -0.42.
PE Ratio-38.46
PS Ratio―
PB Ratio13.45
Price to Fair Value13.45
Price to FCF-40.69
Price to Operating Cash Flow-40.78
PEG Ratio-0.42
Income Statement
In the last 12 months, Belite Bio, Inc. ADR had revenue of 0.00 and earned -31.63M in profits. Earnings per share was -1.19.
Revenue0.00
Gross Profit-399.00K
Operating Income-31.67M
Pretax Income-31.62M
Net Income-31.63M
EBITDA-31.53M
Earnings Per Share (EPS)-1.19
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Belite Bio, Inc. ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.72
52-Week Price Change56.82%
50-Day Moving Average60.97
200-Day Moving Average58.44
Relative Strength Index (RSI)47.28
Average Volume (3m)40.95K
Important Dates
Belite Bio, Inc. ADR upcoming earnings date is May 7, 2025, TBA Not Confirmed.
Last Earnings DateMar 17, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
Belite Bio, Inc. ADR as a current ratio of 24.76, with Debt / Equity ratio of 0.00%
Current Ratio24.76
Quick Ratio24.76
Debt to Market Cap0.00
Net Debt to EBITDA―
Interest Coverage Ratio-1.27K
Taxes
In the past 12 months, Belite Bio, Inc. ADR has paid 9.00K in taxes.
Income Tax9.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Belite Bio, Inc. ADR EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Belite Bio, Inc. ADR has $95.50M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$95.50M billion.
Cash & Marketable Securities$95.50M
Total Debt$0.00
Net Cash-$95.50M
Net Cash Per Share-$2.96
Tangible Book Value Per Share$3.28
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Belite Bio, Inc. ADR is $96.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$96.67
Price Target Upside64.40% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―